Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Rapid Diagnostics Market by Product (Over The Counter Rapid Diagnostics Test, Professional Rapid Diagnostics Test) and by Application (Blood Glucose Rapid Diagnostics, Infectious Diseases Rapid Diagnostics, Cardiometabolic Rapid Diagnostics, Coagulation Rapid Diagnostics, Pregnancy Fertility Rapid Diagnostics, Fecal Occult Blood Rapid Diagnostics, Toxicology Rapid Diagnostics): Global Opportunity Analysis and Industry Forecast, 2023-2032

A03410

Pages: NA

Charts: NA

Tables: NA

Rapid diagnostic test (RDT) is essentially utilized in preliminary or emergency medical screening along with medical facilities that have limited resources. RDTs enable point-of-care testing in primary care by quick and easy operations. Rapid diagnostics is incorporated in several conventional diagnostics tests such as rapid antibody tests including rapid HIV test, rapid plasma regain, and rapid antigen tests that include rapid influenza diagnostic test & malaria antigen detection tests among others.

Rapid diagnostic tests are highly adopted for diagnosis, patient management, epidemiology, and screening. The major factors that fuel the growth of the market are increase in the demand for rapid diagnostic tests in decentralized settings along with rising awareness regarding early diagnosis among people. In addition, the escalating need for inexpensive diagnostic testing coupled with accuracy raises the market growth. However, lack of awareness regarding newer rapid diagnostic tests available in the market restrains the growth of the rapid diagnostics market. Moreover, the rising demand for bedside diagnostic testing will offer profitable opportunities for the growth of the rapid diagnostics market.

The report segments the market on the basis of product, application, and region. Based on product, the market is divided into over-the-counter (OTC) rapid diagnostics test and professional rapid diagnostics test. Based on application, the market is classified into blood glucose rapid diagnostics, infectious diseases rapid diagnostics, cardiometabolic rapid diagnostics, coagulation rapid diagnostics, pregnancy & fertility rapid diagnostics, fecal occult blood rapid diagnostics, and toxicology rapid diagnostics. Based on region, it has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players profiled in this market are Abaxis, Becton, Dickinson and Company, Bio-Rad Laboratories, Accriva Diagnostics, ACON Laboratories, Inc., Hologic, Inc., Abbott Laboratories, Roche Diagnostics, Bayer HealthCare Pharmaceuticals LLC, and Cepheid Inc.

Key Benefits

  • The study provides an in-depth analysis of the global rapid diagnostics market, with current trends and future estimations to elucidate imminent investment pockets.
  • It presents a quantitative analysis to enable stakeholders to capitalize on prevailing market opportunities.
  • Extensive analysis of the market by type assists in understanding various forms of rapid diagnostic available.
  • Key players have been profiled and their strategies thoroughly analyzed, which predict the competitive outlook of the market.

 Key Market Segments

  • By Product
    • Over The Counter Rapid Diagnostics Test
    • Professional Rapid Diagnostics Test
  • By Application
    • Blood Glucose Rapid Diagnostics
    • Infectious Diseases Rapid Diagnostics
    • Cardiometabolic Rapid Diagnostics
    • Coagulation Rapid Diagnostics
    • Pregnancy & Fertility Rapid Diagnostics
    • Fecal Occult Blood Rapid Diagnostics
    • Toxicology Rapid Diagnostics
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA

 
Key Market Players

  • Abaxis
  • ACON Laboratories, Inc.
  • Cepheid Inc.
  • Abbott Laboratories
  • Hologic, Inc.
  • Accriva Diagnostics
  • Bio-Rad Laboratories
  • Bayer HealthCare Pharmaceuticals LLC
  • Becton, Dickinson and Company
  • Roche Diagnostics

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: RAPID DIAGNOSTICS MARKET, BY PRODUCT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product

    • 4.2. Over The Counter Rapid Diagnostics Test

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Professional Rapid Diagnostics Test

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

  • CHAPTER 5: RAPID DIAGNOSTICS MARKET, BY APPLICATION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Application

    • 5.2. Blood Glucose Rapid Diagnostics

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Infectious Diseases Rapid Diagnostics

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Cardiometabolic Rapid Diagnostics

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Coagulation Rapid Diagnostics

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

    • 5.6. Pregnancy And Fertility Rapid Diagnostics

      • 5.6.1. Key Market Trends, Growth Factors and Opportunities

      • 5.6.2. Market Size and Forecast, By Region

      • 5.6.3. Market Share Analysis, By Country

    • 5.7. Fecal Occult Blood Rapid Diagnostics

      • 5.7.1. Key Market Trends, Growth Factors and Opportunities

      • 5.7.2. Market Size and Forecast, By Region

      • 5.7.3. Market Share Analysis, By Country

    • 5.8. Toxicology Rapid Diagnostics

      • 5.8.1. Key Market Trends, Growth Factors and Opportunities

      • 5.8.2. Market Size and Forecast, By Region

      • 5.8.3. Market Share Analysis, By Country

  • CHAPTER 6: RAPID DIAGNOSTICS MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Product

      • 6.2.3. Market Size and Forecast, By Application

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Rapid Diagnostics Market

        • 6.2.5.1. Market Size and Forecast, By Product
        • 6.2.5.2. Market Size and Forecast, By Application

      • 6.2.6. Canada Rapid Diagnostics Market

        • 6.2.6.1. Market Size and Forecast, By Product
        • 6.2.6.2. Market Size and Forecast, By Application

      • 6.2.7. Mexico Rapid Diagnostics Market

        • 6.2.7.1. Market Size and Forecast, By Product
        • 6.2.7.2. Market Size and Forecast, By Application

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Product

      • 6.3.3. Market Size and Forecast, By Application

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Rapid Diagnostics Market

        • 6.3.5.1. Market Size and Forecast, By Product
        • 6.3.5.2. Market Size and Forecast, By Application

      • 6.3.6. Germany Rapid Diagnostics Market

        • 6.3.6.1. Market Size and Forecast, By Product
        • 6.3.6.2. Market Size and Forecast, By Application

      • 6.3.7. Italy Rapid Diagnostics Market

        • 6.3.7.1. Market Size and Forecast, By Product
        • 6.3.7.2. Market Size and Forecast, By Application

      • 6.3.8. Spain Rapid Diagnostics Market

        • 6.3.8.1. Market Size and Forecast, By Product
        • 6.3.8.2. Market Size and Forecast, By Application

      • 6.3.9. UK Rapid Diagnostics Market

        • 6.3.9.1. Market Size and Forecast, By Product
        • 6.3.9.2. Market Size and Forecast, By Application

      • 6.3.10. Russia Rapid Diagnostics Market

        • 6.3.10.1. Market Size and Forecast, By Product
        • 6.3.10.2. Market Size and Forecast, By Application

      • 6.3.11. Rest Of Europe Rapid Diagnostics Market

        • 6.3.11.1. Market Size and Forecast, By Product
        • 6.3.11.2. Market Size and Forecast, By Application

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Product

      • 6.4.3. Market Size and Forecast, By Application

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Rapid Diagnostics Market

        • 6.4.5.1. Market Size and Forecast, By Product
        • 6.4.5.2. Market Size and Forecast, By Application

      • 6.4.6. Japan Rapid Diagnostics Market

        • 6.4.6.1. Market Size and Forecast, By Product
        • 6.4.6.2. Market Size and Forecast, By Application

      • 6.4.7. India Rapid Diagnostics Market

        • 6.4.7.1. Market Size and Forecast, By Product
        • 6.4.7.2. Market Size and Forecast, By Application

      • 6.4.8. South Korea Rapid Diagnostics Market

        • 6.4.8.1. Market Size and Forecast, By Product
        • 6.4.8.2. Market Size and Forecast, By Application

      • 6.4.9. Australia Rapid Diagnostics Market

        • 6.4.9.1. Market Size and Forecast, By Product
        • 6.4.9.2. Market Size and Forecast, By Application

      • 6.4.10. Thailand Rapid Diagnostics Market

        • 6.4.10.1. Market Size and Forecast, By Product
        • 6.4.10.2. Market Size and Forecast, By Application

      • 6.4.11. Malaysia Rapid Diagnostics Market

        • 6.4.11.1. Market Size and Forecast, By Product
        • 6.4.11.2. Market Size and Forecast, By Application

      • 6.4.12. Indonesia Rapid Diagnostics Market

        • 6.4.12.1. Market Size and Forecast, By Product
        • 6.4.12.2. Market Size and Forecast, By Application

      • 6.4.13. Rest of Asia Pacific Rapid Diagnostics Market

        • 6.4.13.1. Market Size and Forecast, By Product
        • 6.4.13.2. Market Size and Forecast, By Application

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Product

      • 6.5.3. Market Size and Forecast, By Application

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Rapid Diagnostics Market

        • 6.5.5.1. Market Size and Forecast, By Product
        • 6.5.5.2. Market Size and Forecast, By Application

      • 6.5.6. South Africa Rapid Diagnostics Market

        • 6.5.6.1. Market Size and Forecast, By Product
        • 6.5.6.2. Market Size and Forecast, By Application

      • 6.5.7. Saudi Arabia Rapid Diagnostics Market

        • 6.5.7.1. Market Size and Forecast, By Product
        • 6.5.7.2. Market Size and Forecast, By Application

      • 6.5.8. UAE Rapid Diagnostics Market

        • 6.5.8.1. Market Size and Forecast, By Product
        • 6.5.8.2. Market Size and Forecast, By Application

      • 6.5.9. Argentina Rapid Diagnostics Market

        • 6.5.9.1. Market Size and Forecast, By Product
        • 6.5.9.2. Market Size and Forecast, By Application

      • 6.5.10. Rest of LAMEA Rapid Diagnostics Market

        • 6.5.10.1. Market Size and Forecast, By Product
        • 6.5.10.2. Market Size and Forecast, By Application

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning, 2024

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. Abaxis

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. Becton, Dickinson And Company

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. Bio-Rad Laboratories

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. Accriva Diagnostics

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. ACON Laboratories, Inc.

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. Hologic, Inc.

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. Abbott Laboratories

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. Roche Diagnostics

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. Bayer HealthCare Pharmaceuticals LLC

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. Cepheid Inc.

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL RAPID DIAGNOSTICS MARKET FOR OVER THE COUNTER RAPID DIAGNOSTICS TEST, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL RAPID DIAGNOSTICS MARKET FOR PROFESSIONAL RAPID DIAGNOSTICS TEST, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL RAPID DIAGNOSTICS MARKET, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL RAPID DIAGNOSTICS MARKET FOR BLOOD GLUCOSE RAPID DIAGNOSTICS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL RAPID DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES RAPID DIAGNOSTICS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL RAPID DIAGNOSTICS MARKET FOR CARDIOMETABOLIC RAPID DIAGNOSTICS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL RAPID DIAGNOSTICS MARKET FOR COAGULATION RAPID DIAGNOSTICS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL RAPID DIAGNOSTICS MARKET FOR PREGNANCY AND FERTILITY RAPID DIAGNOSTICS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL RAPID DIAGNOSTICS MARKET FOR FECAL OCCULT BLOOD RAPID DIAGNOSTICS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL RAPID DIAGNOSTICS MARKET FOR TOXICOLOGY RAPID DIAGNOSTICS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. GLOBAL RAPID DIAGNOSTICS MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. NORTH AMERICA RAPID DIAGNOSTICS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 14. NORTH AMERICA RAPID DIAGNOSTICS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 15. NORTH AMERICA RAPID DIAGNOSTICS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 16. U.S. RAPID DIAGNOSTICS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 17. U.S. RAPID DIAGNOSTICS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 18. CANADA RAPID DIAGNOSTICS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 19. CANADA RAPID DIAGNOSTICS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 20. MEXICO RAPID DIAGNOSTICS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 21. MEXICO RAPID DIAGNOSTICS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 22. EUROPE RAPID DIAGNOSTICS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 23. EUROPE RAPID DIAGNOSTICS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 24. EUROPE RAPID DIAGNOSTICS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 25. FRANCE RAPID DIAGNOSTICS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 26. FRANCE RAPID DIAGNOSTICS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 27. GERMANY RAPID DIAGNOSTICS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 28. GERMANY RAPID DIAGNOSTICS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 29. ITALY RAPID DIAGNOSTICS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 30. ITALY RAPID DIAGNOSTICS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 31. SPAIN RAPID DIAGNOSTICS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 32. SPAIN RAPID DIAGNOSTICS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 33. UK RAPID DIAGNOSTICS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 34. UK RAPID DIAGNOSTICS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 35. RUSSIA RAPID DIAGNOSTICS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 36. RUSSIA RAPID DIAGNOSTICS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 37. REST OF EUROPE RAPID DIAGNOSTICS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 38. REST OF EUROPE RAPID DIAGNOSTICS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 39. ASIA-PACIFIC RAPID DIAGNOSTICS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 40. ASIA-PACIFIC RAPID DIAGNOSTICS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 41. ASIA-PACIFIC RAPID DIAGNOSTICS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 42. CHINA RAPID DIAGNOSTICS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 43. CHINA RAPID DIAGNOSTICS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 44. JAPAN RAPID DIAGNOSTICS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 45. JAPAN RAPID DIAGNOSTICS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 46. INDIA RAPID DIAGNOSTICS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 47. INDIA RAPID DIAGNOSTICS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 48. SOUTH KOREA RAPID DIAGNOSTICS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 49. SOUTH KOREA RAPID DIAGNOSTICS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 50. AUSTRALIA RAPID DIAGNOSTICS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 51. AUSTRALIA RAPID DIAGNOSTICS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 52. THAILAND RAPID DIAGNOSTICS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 53. THAILAND RAPID DIAGNOSTICS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 54. MALAYSIA RAPID DIAGNOSTICS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 55. MALAYSIA RAPID DIAGNOSTICS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 56. INDONESIA RAPID DIAGNOSTICS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 57. INDONESIA RAPID DIAGNOSTICS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 58. REST OF ASIA PACIFIC RAPID DIAGNOSTICS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 59. REST OF ASIA PACIFIC RAPID DIAGNOSTICS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 60. LAMEA RAPID DIAGNOSTICS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 61. LAMEA RAPID DIAGNOSTICS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 62. LAMEA RAPID DIAGNOSTICS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 63. BRAZIL RAPID DIAGNOSTICS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 64. BRAZIL RAPID DIAGNOSTICS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 65. SOUTH AFRICA RAPID DIAGNOSTICS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 66. SOUTH AFRICA RAPID DIAGNOSTICS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 67. SAUDI ARABIA RAPID DIAGNOSTICS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 68. SAUDI ARABIA RAPID DIAGNOSTICS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 69. UAE RAPID DIAGNOSTICS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 70. UAE RAPID DIAGNOSTICS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 71. ARGENTINA RAPID DIAGNOSTICS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 72. ARGENTINA RAPID DIAGNOSTICS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 73. REST OF LAMEA RAPID DIAGNOSTICS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 74. REST OF LAMEA RAPID DIAGNOSTICS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 75. ABAXIS: KEY EXECUTIVES
  • TABLE 76. ABAXIS: COMPANY SNAPSHOT
  • TABLE 77. ABAXIS: OPERATING SEGMENTS
  • TABLE 78. ABAXIS: PRODUCT PORTFOLIO
  • TABLE 79. ABAXIS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 80. BECTON, DICKINSON AND COMPANY: KEY EXECUTIVES
  • TABLE 81. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • TABLE 82. BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
  • TABLE 83. BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
  • TABLE 84. BECTON, DICKINSON AND COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 85. BIO-RAD LABORATORIES: KEY EXECUTIVES
  • TABLE 86. BIO-RAD LABORATORIES: COMPANY SNAPSHOT
  • TABLE 87. BIO-RAD LABORATORIES: OPERATING SEGMENTS
  • TABLE 88. BIO-RAD LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 89. BIO-RAD LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 90. ACCRIVA DIAGNOSTICS: KEY EXECUTIVES
  • TABLE 91. ACCRIVA DIAGNOSTICS: COMPANY SNAPSHOT
  • TABLE 92. ACCRIVA DIAGNOSTICS: OPERATING SEGMENTS
  • TABLE 93. ACCRIVA DIAGNOSTICS: PRODUCT PORTFOLIO
  • TABLE 94. ACCRIVA DIAGNOSTICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 95. ACON LABORATORIES, INC.: KEY EXECUTIVES
  • TABLE 96. ACON LABORATORIES, INC.: COMPANY SNAPSHOT
  • TABLE 97. ACON LABORATORIES, INC.: OPERATING SEGMENTS
  • TABLE 98. ACON LABORATORIES, INC.: PRODUCT PORTFOLIO
  • TABLE 99. ACON LABORATORIES, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 100. HOLOGIC, INC.: KEY EXECUTIVES
  • TABLE 101. HOLOGIC, INC.: COMPANY SNAPSHOT
  • TABLE 102. HOLOGIC, INC.: OPERATING SEGMENTS
  • TABLE 103. HOLOGIC, INC.: PRODUCT PORTFOLIO
  • TABLE 104. HOLOGIC, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 105. ABBOTT LABORATORIES: KEY EXECUTIVES
  • TABLE 106. ABBOTT LABORATORIES: COMPANY SNAPSHOT
  • TABLE 107. ABBOTT LABORATORIES: OPERATING SEGMENTS
  • TABLE 108. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 109. ABBOTT LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 110. ROCHE DIAGNOSTICS: KEY EXECUTIVES
  • TABLE 111. ROCHE DIAGNOSTICS: COMPANY SNAPSHOT
  • TABLE 112. ROCHE DIAGNOSTICS: OPERATING SEGMENTS
  • TABLE 113. ROCHE DIAGNOSTICS: PRODUCT PORTFOLIO
  • TABLE 114. ROCHE DIAGNOSTICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 115. BAYER HEALTHCARE PHARMACEUTICALS LLC: KEY EXECUTIVES
  • TABLE 116. BAYER HEALTHCARE PHARMACEUTICALS LLC: COMPANY SNAPSHOT
  • TABLE 117. BAYER HEALTHCARE PHARMACEUTICALS LLC: OPERATING SEGMENTS
  • TABLE 118. BAYER HEALTHCARE PHARMACEUTICALS LLC: PRODUCT PORTFOLIO
  • TABLE 119. BAYER HEALTHCARE PHARMACEUTICALS LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 120. CEPHEID INC.: KEY EXECUTIVES
  • TABLE 121. CEPHEID INC.: COMPANY SNAPSHOT
  • TABLE 122. CEPHEID INC.: OPERATING SEGMENTS
  • TABLE 123. CEPHEID INC.: PRODUCT PORTFOLIO
  • TABLE 124. CEPHEID INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL RAPID DIAGNOSTICS MARKET SEGMENTATION
  • FIGURE 2. GLOBAL RAPID DIAGNOSTICS MARKET
  • FIGURE 3. SEGMENTATION RAPID DIAGNOSTICS MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN RAPID DIAGNOSTICS MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALRAPID DIAGNOSTICS MARKET
  • FIGURE 11. RAPID DIAGNOSTICS MARKET SEGMENTATION, BY BY PRODUCT
  • FIGURE 12. RAPID DIAGNOSTICS MARKET FOR OVER THE COUNTER RAPID DIAGNOSTICS TEST, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. RAPID DIAGNOSTICS MARKET FOR PROFESSIONAL RAPID DIAGNOSTICS TEST, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. RAPID DIAGNOSTICS MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 15. RAPID DIAGNOSTICS MARKET FOR BLOOD GLUCOSE RAPID DIAGNOSTICS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. RAPID DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES RAPID DIAGNOSTICS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. RAPID DIAGNOSTICS MARKET FOR CARDIOMETABOLIC RAPID DIAGNOSTICS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. RAPID DIAGNOSTICS MARKET FOR COAGULATION RAPID DIAGNOSTICS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. RAPID DIAGNOSTICS MARKET FOR PREGNANCY AND FERTILITY RAPID DIAGNOSTICS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. RAPID DIAGNOSTICS MARKET FOR FECAL OCCULT BLOOD RAPID DIAGNOSTICS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 21. RAPID DIAGNOSTICS MARKET FOR TOXICOLOGY RAPID DIAGNOSTICS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 22. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 23. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 24. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 25. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 26. COMPETITIVE DASHBOARD
  • FIGURE 27. COMPETITIVE HEATMAP: RAPID DIAGNOSTICS MARKET
  • FIGURE 28. TOP PLAYER POSITIONING, 2024
  • FIGURE 29. ABAXIS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 30. ABAXIS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 31. ABAXIS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 32. BECTON, DICKINSON AND COMPANY: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 33. BECTON, DICKINSON AND COMPANY: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 34. BECTON, DICKINSON AND COMPANY: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 35. BIO-RAD LABORATORIES: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 36. BIO-RAD LABORATORIES: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 37. BIO-RAD LABORATORIES: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 38. ACCRIVA DIAGNOSTICS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 39. ACCRIVA DIAGNOSTICS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 40. ACCRIVA DIAGNOSTICS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 41. ACON LABORATORIES, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 42. ACON LABORATORIES, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 43. ACON LABORATORIES, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 44. HOLOGIC, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 45. HOLOGIC, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 46. HOLOGIC, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 47. ABBOTT LABORATORIES: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 48. ABBOTT LABORATORIES: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 49. ABBOTT LABORATORIES: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 50. ROCHE DIAGNOSTICS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 51. ROCHE DIAGNOSTICS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 52. ROCHE DIAGNOSTICS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 53. BAYER HEALTHCARE PHARMACEUTICALS LLC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 54. BAYER HEALTHCARE PHARMACEUTICALS LLC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 55. BAYER HEALTHCARE PHARMACEUTICALS LLC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 56. CEPHEID INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 57. CEPHEID INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 58. CEPHEID INC.: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Rapid Diagnostics Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved